Biogen Idec, Elan resume Tysabri trials
BusinessWeek - USA
... said Wednesday they have resumed Tysabri trials and dosed the first patients in the monotherapy safety extension study program for multiple sclerosis. ...
See all stories on this topic

Biogen-Tysabri reinitiate Tysabri trial
Eyewitness News - East Providence,RI,USA
NEW YORK Biogen Idec and Elan Corporation have resumed trials of the multiple sclerosis drug Tysabri (ty-SAH'-bree). It was pulled ...